Schizophrenia trials in Israel
6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Where
- Ashkelon, Jerusalem, Petah Tikva, Ramat Gan
- Age
- 55 years to 90 years
- People
- 406 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00 - Phase 3Taking peopleStratification and Treatment in Early Psychosis Study - ENHANCE
- Where
- Hod HaSharon, Petah Tikva, Ramat Gan
- Age
- 16 years to 40 years
- People
- 250 worldwide
- Run by
- University of Oxford
See details and how to joinNCT06778564 · EU 2025-521929-32-00 - Phase 3Not yet taking people in IsraelStratification and Treatment in Early Psychosis Study -ASSIST
- Where
- Hod HaSharon, Petah Tikva, Ramat Gan
- Age
- 16 years to 50 years
- People
- 250 worldwide
- Run by
- University of Oxford
See details and how to joinNCT07326124 - Phase 2Taking peopleCombination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia
- Where
- Jerusalem
- Age
- 18 years to 40 years
- People
- 80
- Run by
- Amit Lotan
See details and how to joinNCT07759895 - No phaseTaking peopleA Closed Unit Incorporating Soteria Elements Versus a Conventional Closed Psychiatric Ward
- Where
- Jerusalem
- Age
- 18 years and over
- People
- 200
- Run by
- Jerusalem Mental Health Center
See details and how to joinNCT07836348 - Phase 1/2Taking peoplePharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine
- Where
- Beersheba, Ness Ziona, Ramat Gan, Tel Aviv
- Age
- 18 years to 64 years
- People
- 24 worldwide
- Run by
- Mapi Pharma Ltd.
See details and how to joinNCT07185815